Evidence map›Paper›PMID 28630063›Full record

ArticleInfection and immunity2017

Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active

Qingmei Jia, Barbara Jane Dillon, Saša Masleša-Galić, Marcus A Horwitz

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. mBio · 2022
    Article
  2. Review
  3. Review
  4. Heterologous Boosting WithFrontiers in immunology · 2020
    Article
  5. Innate and Adaptive Immune Responses duringMicrobiology spectrum · 2019
    Article
  6. InactivatedFrontiers in immunology · 2019
    Article
  7. Vaccines · 2018
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qingmei JiaDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
Barbara Jane DillonDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
Saša Masleša-GalićDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
Marcus A HorwitzDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of California-Los Angeles, Los Angeles, California, USA MHorwitz@mednet.ucla.edu.
University of California, Los Angeles · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G · 1991 to 2018
$39.9M
IMMUNOPROTECTIVE DETERMINANTS OF M TUBERCULOSIS IN AIDSR01AI031338 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HORWITZ, MARCUS AARON · 1991 to 2010
$6.3M
NCI NIH HHS P30 CA016042NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI031338
6 · The paper itself

Abstract

A potent vaccine against tuberculosis, one of the world's deadliest diseases, is needed to enhance the immunity of people worldwide, most of whom have been vaccinated with the partially effective

Indexed as

30-kDa major secretory proteinantigen 85Bheterologous prime-boost vaccinationListeria vectorMycobacterium tuberculosisprfAPrfAr30vaccine

Identifiers

PMID28630063
PMCPMC5563566
OpenAlexW2717946203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.